drugset / Trial / NCT00441181

Effects of Travoprost on Neovascular Glaucoma

NCT00441181

Withdrawn 40 enrolled Federal University of São Paulo
RandomizedParallel-groupDouble-blindTreatment

Summary

Prostaglandin analogues have not been used in the treatment of neovascular glaucoma because of suspicious lack of efficacy. This study aims at assessing the effect of travoprost on neovascular glaucoma.

Timeline

Start
2008-01
Primary completion
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Travoprost Other / unclassified

Indications